Frontlight ResearchEarly access
CompletedPhase 4
Evaluation of Efficacy of Skål Pro Powder on Symptoms of Irritable Bowel Syndrome
Key facts
- Who runs it
- EP Plus Group Sdn Bhd
- Where
- Malaysia1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Completed
- Phase
- Phase 4
- People taking part
- 57 people enrolled
- Started
- 17 Oct 2024
- Ended
- 14 Apr 2026
- Type of study
- Interventional, 2 groupsOne group gets a placebo (a dummy treatment), for comparison.
- Treatments tested
- Skal Pro
- Placebo
- Record updated
- 11 September 2026
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 13 criteriaShow less
Who can take part
- IBS diagnosed using the Rome IV criteria
- Age above 18 years old and any gender
- Any subtypes of IBS (diarrhea, constipation or mixed)
Who cannot take part
- Previous abdominal surgeries
- Was previously prescribed probiotic Skal Pro™ (LP299V™)
- Presence of red flag symptoms (weight loss, anemia, night symptoms, abdominal mass, strong family history of cancer)
- Medical conditions that contraindicate probiotic use including severe sepsis and pregnancy
- Presence of bowel malignancy
- Diagnosis of bowel infection within the past one month
- Patients with overt psychiatric illnesses including schizophrenia and manic disorders
- A history of allergy to probiotic
- Was prescribed antibiotic (s) within the past one month
- Was prescribed probiotic (s) within the past one month
Where is this trial?
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
The objective of this randomized, double-blind, placebo-controlled study is to evaluate the effectiveness of Skal Pro in alleviating symptoms, enhancing stool consistency, improving quality of life, and addressing psychological distress in individuals diagnosed with irritable bowel syndrome (IBS), as compared to those who receive no intervention.
The 2 groups in the trial
- Skal ProTreatment being tested
Skal Pro in the form of 2g sachet powder contains 10 billion CFU of freeze-dried Lactobacillus plantarum 299v (LP299V) and galactooligosaccharides (GOS).
- PlaceboPlacebo, for comparison
Placebo is an oral formulation of inert powder. Placebo and Skal Pro are identical in shape, size, colour, packaging and taste.
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- A Randomized Double-Blind Placebo-controlled Clinical Trial on the Efficacy of Skål Pro (Lactobacillus Plantarum 299 and Galacto-oligosaccharides) in Improving Severity of Symptoms, Stool Forms, Quality of Life and Psychological Dysfunction in Patients With Irritable Bowel Syndrome (IBS)
- Record updated
- 11 September 2026